Frequency of self-reported prevalent cardiovascular disease, by gender, age group, and presence of MS (by ATPIII and IDF definitions), or a diagnosis of new or pre-existing DM
| Males | Females | |||||
|---|---|---|---|---|---|---|
| Prevalent CVD | 25–44 | 45–64 | 64+ | 25–44 | 45–64 | 64+ |
| Overall | 1 (0.6%) | 21 (9.5%) | 42 (26.6%) | 4 (1.4%) | 12 (3.9%) | 33 (16.1%) |
| No MS (ATPIII) | 1 (0.7%) | 9 (6.1%) | 23 (23.5%) | 1 (0.4%) | 4 (1.8%) | 23 (16.9%) |
| MS (ATPIII) | 0 (0%) | 12 (16%) | 19 (31.7%) | 3 (9.1%) | 8 (9.1%) | 10 (14.5%) |
| OR MS vs no MS (95% CI) | NA | 2.92 (1.17 to 7.29) | 1.51 (0.74 to 3.1) | 24.3 (2.4 to 241) | 5.33 (1.56 to 18.17) | 0.83 (0.37 to 1.87) |
| p Value | NA | 0.017 | 0.26 | 0.0001 | 0.003 | 0.66 |
| No MS (IDF) | 1 (0.8%) | 7 (5.8%) | 21 (25.9%) | 1 (0.4%) | 2 (1.0%) | 17 (15.6%) |
| MS (IDF) | 0 (0%) | 14 (13.7%) | 21 (27.3%) | 3 (7.0%) | 10 (9.6%) | 16 (16.7%) |
| OR MS vs no MS (95% CI) | NA | 2.57 (1 to 6.63) | 1.07 (0.53 to 2.17) | 17.48 (1.77 to 172) | 10.59 (2.27 to 49.3) | 1.08 (0.51 to 2.28) |
| p Value | NA | 0.045 | 0.85 | 0.0009 | 0.0002 | 0.84 |
| No DM | 1 (0.6%) | 17 (8.4%) | 32 (24.8%) | 4 (1.4%) | 9 (3.2%) | 26 (15.5%) |
| DM | 0 (0%) | 4 (20%) | 10 (34.5%) | 0 (0%) | 3 (13.6%) | 7 (18.4%) |
| OR DM vs no DM (95% CI) | NA | 2.72 (0.82 to 9.06) | 1.6 (0.67 to 3.78) | NA | 4.8 (1.2 to 19.2) | 1.23 (0.49 to 3.09) |
| p Value | NA | 0.09 | 0.29 | NA | 0.01 | 0.65 |
CVD, cardiovascular disease; DM, diabetes mellitus; MS, metabolic syndrome; NA, not applicable.